Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild and Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02007291
What this trial is testing

Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment

Who this might be right for
Late Onset Alzheimer
Federal University of Minas Gerais 71
Large-scale testing (Phase 3)WithdrawnNCT04187547
What this trial is testing

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Who this might be right for
Alzheimer's Disease
Cerecin
Large-scale testing (Phase 3)UnknownNCT01094340
What this trial is testing

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Banner Health 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04639050
What this trial is testing

Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 241
Not applicableUnknownNCT04495686
What this trial is testing

An Innovative Supportive Care Model for Dementia and Traumatic Brain Injury

Who this might be right for
Dementia, MixedDementia MildDementia Moderate+2 more
University of Virginia 171
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Large-scale testing (Phase 3)Ended earlyNCT04886063
What this trial is testing

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
LeonaBio 423
Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Early research (Phase 1)Study completedNCT01850238
What this trial is testing

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Large-scale testing (Phase 3)Study completedNCT00423085
What this trial is testing

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 859
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Early research (Phase 1)UnknownNCT05016427
What this trial is testing

Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
VTBIO Co. LTD 12
Post-approval studies (Phase 4)UnknownNCT05383183
What this trial is testing

Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Daewoong Bio Inc. 630
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Testing effectiveness (Phase 2)Study completedNCT00359944
What this trial is testing

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Sumitomo Pharma America, Inc. 171
Early research (Phase 1)Study completedNCT01125631
What this trial is testing

Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 8
Not applicableLooking for participantsNCT06584357
What this trial is testing

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseAlzheimer's Disease, Early Onset+3 more
GAP Innovations, PBC 1,200
Early research (Phase 1)Study completedNCT02640092
What this trial is testing

Longitudinal Evaluation of [18F]GTP1 as a PET Radioligand for Imaging Tau in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 72
Early research (Phase 1)Study completedNCT03822208
What this trial is testing

First in Human Study for Safety and Tolerability of AL003.

Who this might be right for
HealthyAlzheimer Disease
Alector Inc. 54
Testing effectiveness (Phase 2)Study completedNCT00568776
What this trial is testing

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
OPKO Health, Inc. 353
Next Page